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October 2015 and retrospectively analysed, providing 141 
dose measurements for all the MOSkins. Measured and 
calculated contributions by each single catheter were 
quantified separately. Discrepancies were plotted depending 
on weighted average polar angles and distances between 
MOSkins and source, and a linearly fitting CF was calculated. 
 
Results: A correction function CF linearly depending on the 
weighted average distance and polar angle of the catheter 
from the dosimeter was obtained (R=0.35, showing a 
significant correlation). The results showed an increase in 
sensitivity of MOSkins at higher distances (i.e., due to 
radiation softening) and at wider polar angles (i.e., due to 
increased radiation contamination by the presence of the 
TRUS probe). The percentage dose discrepancy between 
calculated and measured dose contribution from each single 
catheter with and without the application of obtained CF 





Conclusion: The use of the CF significantly reduces 
percentage discrepancy between planned and measured dose 
per single catheter. Implementation of the CF to correct 
MOSkin readings online is a further step towards accurate and 
reliable real time IVD in prostate BT performed with the DPP. 
Based on the real time measured dose discrepancy, the next 
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Purpose or Objective: Rotating shield brachytherapy (RSBT) 
is an intensity modulated high dose rate (HDR) BT treatment 
technique, where radiation sources are surrounded by 
catheters containing rotating shields that direct radiation 
towards the tumour and away from healthy tissues. RSBT for 
HDR requires sources with lower energies than Ir-192, such as 
Gd-153 and Se-75, due to shield thickness constraints. The 
distinct features of shield angle, catheter material and 
source isotope require the development of a specific Monte 
Carlo (MC)-based treatment planning and optimization 
system. 
 
Material and Methods: An MC based dose calculation engine 
for RSBT has been developed and coupled with a column-
generation optimizer. At every iteration of the optimization 
loop, the column-generation process solves a pricing problem 
to determine the best dwell position and shield angle 
combination to add to the treatment plan, resulting in the 
best possible plan with the shortest treatment time. 
As a source model, the microSelectron-v2 source geometry 
was selected and placed inside a cylindrical platinum shield 
with a diameter of 1.8 mm and 3.0 mm for interstitial and 
intracavitary cases, respectively. An emission window 
coinciding with the active core of the source was created by 
removing half (180º) of the wall of the shield. 
For an interstitial prostate case, RSBT plans were generated 
only using Gd-153 as a source due to the extreme limitations 
on shield size in interstitial catheters. For the intracavitary 
GYN case, both Gd-153 and Se-75 plans were generated. All 
RSBT plans were compared with conventional HDR BT. Only 
the original dwell positions used in conventional BT were 
sampled to create the RSBT plans. 
 
Results: RSBT plans resulted in a considerable reduction in 
both rectum and bladder doses without sacrificing target 
coverage for the prostate case. With 95% of the PTV volume 
receiving over 15 Gy, only 40% of the rectum volume received 
more than 2 Gy for the Gd-153 RSBT case,as opposed to 85% 
for the unshielded Ir-192 conventional plan. 
 
 
For the GYN patient, the median rectum dose was 2.4 Gy, 3.2 
Gy and 3.45 Gy for Gd-153 RSBT, Se-75 RSBT and unshielded 
Ir-192, respectively, with an identical target coverage. The 
Gd-153 case was also able to reduce the dose to the bladder 
by 41%. 
 
Conclusion: The development of the first MC-based TPS 
devoted to RSBT has been successfully accomplished. For the 
prostate case, a significant dosimetric improvement was 
achieved over conventional BT using Gd-153 with optimized 
shield angles. For the GYN case, the improvement was 
diminished by the central position of the conventional BT 
dwell positions within the target volume. RSBT allows the 
placement of dwell positions much closer to normal tissue, 
which will yield superior dose distributions when properly 
optimized. RSBT will decrease normal tissue toxicity and 
allow for tailoring treatments to each individual patient by 
treating all parts of the tumour without over-irradiation of 
large regions of normal tissues. 
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Purpose or Objective: Acute dysphagia is a frequently 
observed toxicity during concurrent chemo-radiation (CRT) or 
high-dose radiotherapy (RT) for lung cancer. This toxicity can 
lead to hospitalizations, treatment interruptions and 
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consequently reduce chances of survival. Models to predict 
acute dysphagia are available. However, these models were 
based on limited amounts of data and the performance of 
these models needs improvements before implementation 
into routine practice. Furthermore, Bayesian network models 
are shown to perform better than conventional modeling 
techniques on datasets with missing values, which is a 
common problem in routine clinical care. In this work, we 
train a Bayesian network model on a large clinical datasets, 
originating predominantly from routine clinical care, to 
accurately predict acute dysphagia in NSCLC patients during 
and shortly after (C)RT. 
 
Material and Methods: Clinical data from 1250 inoperable 
NSCLC patients, treated with radical CRT, sequential chemo-
radiation or RT alone were collected. The esophagus was 
delineated using the external esophageal contour from the 
cricoid cartilage to the GE junction. A Bayesian network 
model was developed to predict severe acute dysphagia (≥
Grade 3 according to the CTCAEv3.0 or v4.0). The model 
utilized age, mean esophageal dose, timing of chemotherapy 
and N-stage to make predictions. Variable selection and 
structure learning was done using the PC-algorithm. The 
model was trained on data from 1250 patients. The model’s 
performance was assessed internally and on an external 
validation set (N=218) from the United Kingdom. Model 
discriminative performance was expressed as the Area Under 
the Curve (AUC) of the Receiver Operating Characteristic 
(ROC). ROCs were compared using the method proposed by 
DeLong and colleagues. Model performance was also assessed 
in terms of calibration. Calibration refers to the agreement 
between the observed frequencies and the predicted 
probabilities and is expressed as the coefficient of 
determination (r2). 
 
Results: One-hundred forty patients (11,2%) developed acute 
dysphagia (≥ Grade 3 according to the CTCAEv3.0 or v4.0). 
The model was first validated internally, by validating on the 
training cohort (N=1250, AUC = 0.77, 95% CI: 0.7325-0.8086, 
r2 = 0.99). Subsequently, the model was externally validated 
on a UK dataset (N = 218, AUC = 0.81, 95% CI: 0.74-0.88, r2 = 
0.64). The ROC curves were not significantly different (p = 
0.28). 
 
Conclusion: The Bayesian network model can make accurate 
predictions of acute dysphagia (AUC = 0.77, 0.81 in the 
internal and external validation respectively), making it a 
powerful tool for clinical decision support. 
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Purpose or Objective: In the Dutch prostate hypo-
fractionation trial (19x3.4Gy versus 39x2Gy) a higher 
incidence of acute gastro-intestinal toxicity was observed in 
the experimental arm. We performed model estimations 
using various alpha/beta ratios to determine whether this 
difference can be explained according to the linear-quadratic 
model. 
 
Material and Methods: Patients with localized prostate 
cancer were randomized between standard fractionation 
(SF=5x2Gy per week, N=293) and hypo-fractionation 
(HF=3x3.4Gy per week, N=285). Proctitis (grade ≥2) was 
defined as moderate to severe mucous or blood loss, or mild 
mucous or blood loss combined with at least 2 other 
complaints: diarrhea, incontinence, tenesmus, cramps, pain. 
Peak incidences over treatment weeks 4 and 6 were available 
from prospectively collected patient reports. Normalized 
Total Dose (NTD, 2Gy equivalent) was accumulated per week 
for alpha/beta ratios of 3, 5, 10, and ∞ (=physical dose), and 
used to derive relative Dose-Surface Histograms (DSHs) of the 
delineated anorectum for each patient. Maximum likelihood 
logistic regressions were performed using a DSH point as 
variable. Univariate (UV) models and multivariate (MV) 
models with fractionation schedule as factor were 
constructed. 
 
Results: Acute proctitis incidences were highest for hypo-
fractionation (SF: n=67; 22.9%, HF: n=98; 34.3%, p<0.01). The 
7Gy/week DSH point correlated well with proctitis, and was 
used for subsequent modeling. Figure 1 illustrates the models 
for the various alpha/beta ratios, and incidences for five 
(roughly) equal size patient bins. Note that the NTD 
correction decreases the surface areas that receive <2Gy per 
day, and increases surfaces receiving >2Gy. The central NTD 
values of the patient bins therefore lie at higher values for 
HF than for SF. The MV models have higher likelihood than 
the UV models, but likelihood for different alpha/beta ratios 
is similar. All MV models have odds ratios >1.5 (p<0.05) for HF 
versus SF, i.e. fractionation remains a factor. 
 
Conclusion: Linear-quadratic dose correction cannot explain 
the observed acute rectum toxicity difference between hypo-
fractionated and standard treatment in patients with 
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